ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print December 19, 2007
Eur Respir J 2007, doi:10.1183/09031936.00088907
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
31/4/822    most recent
09031936.00088907v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schelstraete, P.
Right arrow Articles by De Baets, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schelstraete, P.
Right arrow Articles by De Baets, F.


ORIGINAL ARTICLE

Pseudomonas aeruginosa in the Home Environment of Newly Infected Cystic Fibrosis Patients

P. Schelstraete 1*, S. Van daele 1, K. De Boeck 2, M. Proesmans 2, P. Lebecque 3, J. Leclercq-Foucart 4, A. Malfroot 5, M. Vaneechoutte 6, F. De Baets 1

1 Cystic Fibrosis Centre Ghent University Hospital, Ghent, Belgium
2 Cystic Fibrosis Centre University Hospital KULeuven, Leuven, Belgium
3 Cystic Fibrosis Centre University Hospital UCL, Louvain-la-Neuve, Belgium
4 Cystic Fibrosis Centre University Hospital ULG, Liège, Belgium
5 Cystic Fibrosis Centre University Hospital UZBrussel, Brussels, Belgium
6 Dept of Clinical Chemistry, Bacteriology and Immunology, Ghent University Hospital, Ghent, Belgium

* To whom correspondence should be addressed. E-mail: petra.schelstraete{at}ugent.be.


   Abstract

The source of acquisition of Pseudomonas aeruginosa in cystic fibrosis (CF) patients remains unknown. Patient-to-patient-transmission has been well documented, but the role of the environment as a source of initial infection is as yet unclear. Here we studied the origin of the first P. aeruginosa isolate in CF patients by comparing the P. aeruginosa genotype(s) from newly infected patients with genotypes of P. aeruginosa isolates from the home environment and from other patients from the same CF centre.

Fifty newly infected patients were studied. P. aeruginosa could be cultured from 5.9% of the environmental samples, corresponding to 18 patients. For 9 of these the genotype of the environmental P. aeruginosa isolate was identical to the patient's isolate. In total, 72% of the environmental P. aeruginosa isolates were encountered in the bathroom. Patient-to-patient transmission within the CF centre could not be ruled out for 3 patients.

In summary, we found a low prevalence of P. aeruginosa in the home environment of the newly infected CF patients. The bathroom should be targeted in any preventive cleaning procedures. An environmental source of the new infection could not be ruled out in 9 patients.

Keywords:  Cystic fibrosis, environment, genotyping, Pseudomonas aeruginosa




This article has been cited by other articles:


Home page
Chronic Respiratory DiseaseHome page
T. Lee
Eradication of early Pseudomonas infection in cystic fibrosis
Chronic Respiratory Disease, May 1, 2009; 6(2): 99 - 107.
[Abstract] [PDF]


Home page
Eur Respir JHome page
J. Barben and J. Schmid
Dental units as infection sources of Pseudomonas aeruginosa
Eur. Respir. J., October 1, 2008; 32(4): 1122 - 1123.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the European Respiratory Society.